France· FR:68368699
ARANESP 150 microgrammes, solution injectable en stylo prérempli
A medicinal product containing darbépoétine alfa, registered in France by AMGEN EUROPE, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- DARBÉPOÉTINE ALFA
- Manufacturer
- AMGEN EUROPE
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009365933741 stylo prérempli en verre (SureClick) de 0,3 mlEUR 153.94
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Darbépoétine alfa in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaARANESPAmgen Europe B.V., Breda
- FinlandAranespParanova Oy
- Japanダルベポエチンアルファ（遺伝子組換え）協和キリン
- SpainARANESP 10 microgramos SOLUCION INYECTABLE EN JERINGA PRECARGADAAmgen Europe B.V.
- IcelandAranespAmgen Europe B.V.*
- SwedenAranesp 10 mikrogram Injektionsvätska, lösning i förfylld injektionspennaAmgen Europe B.V.
- BelgiumAranesp 10 µg/0.4 mlAmgen Europe
- NetherlandsAranesp 10 microgram, oplossing voor injectie in een voorgevulde pen (SureClick)Amgen Europe B.V.
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Aranesp
- Norway · Aranesp
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bd9e57cb-ce8c-4472-a7ad-383268077bbd GET /v1/drugs/bd9e57cb-ce8c-4472-a7ad-383268077bbd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "68368699",
"date_amm": "2005-02-28",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/01/185",
"substance": "DARBÉPOÉTINE ALFA",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable",
"voies_administration": "sous-cutanée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about darbépoétine alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.